BIOMARIN PHARMACEUTICAL INC
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Large accelerated filer
State of Incorporation
DE
Business Address
105 DIGITAL DRIVE, NOVATO, CA, 94949
Mailing Address
105 DIGITAL DRIVE, NOVATO, CA, 94949
Phone
4155066700
Fiscal Year End
1231
EIN
680397820
Financial Overview
FY2025
$1.51B
Total Liabilities
$4.95B
Stockholders' Equity
$1.31B
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | March 26, 2026 | View on SEC |
| 4 Insider stock transaction report | March 19, 2026 | View on SEC |
| 4 Insider stock transaction report | March 19, 2026 | View on SEC |
| 4 Insider stock transaction report | March 19, 2026 | View on SEC |
| 4 Insider stock transaction report | March 19, 2026 | View on SEC |
| 4 Insider stock transaction report | March 18, 2026 | View on SEC |
| 4 Insider stock transaction report | March 18, 2026 | View on SEC |
| 4 Insider stock transaction report | March 17, 2026 | View on SEC |
| 4 Insider stock transaction report | March 17, 2026 | View on SEC |
| 4 Insider stock transaction report | March 17, 2026 | View on SEC |
Material Events
8-K
Strategy Change
March 16, 2026
High Impact
- VOXZOGO is already a successful and revenue-generating drug for achondroplasia, which remains unaffected.
- Trials for VOXZOGO in children with Noonan syndrome and most cases of idiopathic short stature (ISS) will continue as planned.
8-K
Strategy Change
December 22, 2025
High Impact
- BioMarin Pharmaceutical Inc. has stopped the development of BMN 349, an oral drug for Alpha-1 antitrypsin deficiency (AATD)-associated liver disease.
- This decision represents a significant setback, as it means a substantial investment of time, money, and resources will not result in a marketable product.
Insider Trading
STRONG SELL
3 insiders
3 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.